Insiders · MPLT

MPLT insider transactions

MapLight Therapeutics Inc. (MPLT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for MPLT

• 8d
  SEC Form 4 filed by Foff Erin Pennock

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 8d
  SEC Form 4 filed by Lillie James Woodruff

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 8d
  SEC Form 4 filed by Hanson Kristopher

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 8d
  SEC Form 4 filed by Gillis Jonathan

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 8d
  SEC Form 4 filed by Kreitzer Anatol

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 8d
  SEC Form 4 filed by Setia Vishwas

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 8d
  SEC Form 4 filed by Kroeger Christopher A.

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 8d
  SEC Form 4 filed by Malenka Robert C.

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 60d
  Director Malenka Robert C. sold $260,398 worth of Voting Common Stock (14,195 units at $18.34), decreasing direct ownership by 4% to 325,059 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 64d
  Director Pavlov George bought $441,168 worth of Voting Common Stock (25,000 units at $17.65) (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 66d
  Director Malenka Robert C. sold $220,632 worth of Voting Common Stock (12,116 units at $18.21), decreasing direct ownership by 3% to 339,254 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 72d
  Director Malenka Robert C. sold $124,329 worth of Voting Common Stock (6,863 units at $18.12), decreasing direct ownership by 2% to 351,370 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 72d
  Director Garnett Timothy John bought $252,678 worth of Voting Common Stock (14,124 units at $17.89) (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 75d
  CAAO and PAO Gillis Jonathan was granted 6,020 units of Voting Common Stock, increasing direct ownership by 2% to 254,523 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 75d
  Chief Scientific Officer Lillie James Woodruff was granted 7,730 units of Voting Common Stock, increasing direct ownership by 3% to 298,862 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 75d
  Chief Financial Officer Setia Vishwas was granted 7,730 units of Voting Common Stock, increasing direct ownership by 2% to 395,549 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 75d
  Chief Discovery Officer Kreitzer Anatol was granted 6,020 units of Voting Common Stock, increasing direct ownership by 2% to 259,928 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 75d
  General Counsel Hanson Kristopher was granted 7,730 units of Voting Common Stock, increasing direct ownership by 4% to 191,582 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 75d
  Chief Executive Officer Kroeger Christopher A. was granted 23,145 units of Voting Common Stock, increasing direct ownership by 1% to 1,649,751 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 75d
  Chief Medical Officer Foff Erin Pennock was granted 13,360 units of Voting Common Stock, increasing direct ownership by 3% to 403,835 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 80d
  Director Malenka Robert C. sold $126,861 worth of Voting Common Stock (7,040 units at $18.02), decreasing direct ownership by 2% to 358,233 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 85d
  Director Malenka Robert C. sold $635,857 worth of Voting Common Stock (34,398 units at $18.49), decreasing direct ownership by 9% to 365,273 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 86d
  Chief Financial Officer Setia Vishwas covered exercise/tax liability with 33,382 units of Voting Common Stock, decreasing direct ownership by 8% to 387,819 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 86d
  CAAO and PAO Gillis Jonathan covered exercise/tax liability with 22,050 units of Voting Common Stock, decreasing direct ownership by 8% to 248,503 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 86d
  Chief Scientific Officer Lillie James Woodruff covered exercise/tax liability with 45,055 units of Voting Common Stock, decreasing direct ownership by 13% to 291,132 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 86d
  Chief Discovery Officer Kreitzer Anatol covered exercise/tax liability with 42,099 units of Voting Common Stock, decreasing direct ownership by 14% to 253,908 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 86d
  Chief Executive Officer Kroeger Christopher A. covered exercise/tax liability with 204,146 units of Voting Common Stock, decreasing direct ownership by 11% to 1,626,606 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 86d
  General Counsel Hanson Kristopher covered exercise/tax liability with 26,007 units of Voting Common Stock, decreasing direct ownership by 12% to 183,852 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 86d
  Chief Medical Officer Foff Erin Pennock covered exercise/tax liability with 44,616 units of Voting Common Stock, decreasing direct ownership by 10% to 390,475 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 158d
  Amendment: SEC Form 3 filed by new insider Pavlov George

  3/A - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 177d
  Large owner Novo Holdings A/S converted options into 2,733,681 units of Voting Common Stock and bought $16,199,997 worth of Voting Common Stock (952,941 units at $17.00) (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 178d
  Large owner Catalyst4, Inc. converted options into 14,256,288 units of Voting Common Stock and bought $92,499,992 worth of Voting Common Stock (5,441,176 units at $17.00) (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)